Cryopreservation Solution
Cryopreservation Solution - Related Videos
07:05
Isolation and Cryopreservation of Neonatal Rat Cardiomyocytes
0 Views •
Cited by 49 •
2015
The isolation of neonatal rat cardiomyocytes is a time consuming and unpredictable procedure. This study describes methods for cryopreservation and thawing of neonatal rat cardiomyocytes that allows for more efficient use of cells. The thawed NRCMs can be used for various experiments without the need for performing isolations each time.
07:06
Mouse Sperm Cryopreservation and Recovery using the I·Cryo Kit
0 Views •
Cited by 5 •
2011
Here we demonstrate the newly developed I•Cryo kit for mouse sperm cryopreservation. Two-cell stage embryo development with frozen-thawed sperm was improved consistently in 5 mouse strains with the use of this kit. Over a 1.5 year period, 49 genetically modified mouse lines were archived by sperm cryopreservation with the I•Cryo kit and later successfully recovered by IVF.
11:10
Cryopreservation of Preimplantation Embryos of Cattle, Sheep, and Goats
0 Views •
Cited by 23 •
2011
Preimplantation embryos may be cryopreserved after placement into a hypertonic cryoprotective solution to cause cellular dehydration. After equilibration, ice crystal formation is induced in the solution surrounding the embryo. Further dehydration occurs as the embryo is slowly cooled to subzero temperatures before plunging into liquid nitrogen for storage.
11:01
A High-Throughput Method For Zebrafish Sperm Cryopreservation and In Vitro Fertilization
0 Views •
Cited by 29 •
2009
This is a high-throughput sperm cryopreservation protocol for zebrafish. Sperm cryopreserved using this protocol has an average of 25% fertility in subsequent vitro fertilization and is stable over many years.
02:35
Long-Term Cryopreservation of Cyanobacterial Strains Using Glycerol or Dimethyl Sulfoxide
0 Views •
2025
Source: Lea-Smith, D. J., et al. Generation of Marked and Markerless Mutants in Model Cyanobacterial Species. J. Vis. Exp. (2016)This video demonstrates the cryopreservation of cyanobacterial strains by combining concentrated cell suspensions with glycerol or DMSO and storing them at low temperatures, enabling long-term maintenance of viable cultures for photosynthesis and genetic studies.
FAQs
Cryoprotective agents reduce the damaging effects of ice formation as temperature falls. They help limit ice crystal development, cellular dehydration, and osmotic stress, while supporting the integrity of membranes and proteins. Because these effects continue during both cooling and warming, the solution’s protective performance can influence whether preserved cells retain viability and function after thawing.
Ice crystals can disrupt cellular structures, while changes in water movement can produce dehydration and osmotic stress. These physical effects may compromise membranes and proteins, reducing post-thaw viability or function. A suitable cryopreservation solution addresses these hazards together rather than focusing only on lowering temperature, making formulation an important factor in preserving biological material.
The solution provides chemical protection, but controlled cooling helps manage how biological material responds as temperature decreases. Together, they reduce the likelihood that freezing will cause excessive ice formation, dehydration, or osmotic disturbance. This combined approach is important because the solution’s effectiveness depends not only on its composition but also on the conditions used during the freezing process.
Recovery depends on how well the cryopreservation solution protects membranes and proteins, how effectively freezing-related ice formation and osmotic stress are limited, and whether controlled cooling and very-low-temperature storage are used appropriately. The decisive outcome is post-thaw viability and function, which can determine whether stored cells, tissues, or other materials remain useful for later bioengineering work.
A general workflow combines biological material with the selected solution, applies controlled cooling, stores the material at very low temperatures, and then thaws it before assessing recovery. The assessment focuses on whether viability and function have been maintained. This sequence supports systematic evaluation of the solution and the surrounding storage conditions rather than treating freezing as an isolated step.
Researchers may use them when cell banking, tissue engineering, regenerative medicine, organoid research, or engineered biological products require biological material to remain available over time. In these settings, preservation is valuable only if thawed material retains relevant viability and function. The solution therefore supports continuity between preparation, storage, and later experimental or development activities.
Post-thaw evaluation examines whether the preserved material remains viable and functional after storage and warming. These outcomes reveal how effectively the formulation limited ice-related damage, dehydration, osmotic stress, and loss of membrane or protein integrity. Comparing recovery across preservation conditions can help bioengineering researchers judge whether a solution is suitable for banking or downstream applications.
Cryopreservation can provide a way to store biological materials used in organoid research and the development of engineered biological products while preserving their later utility. Its relevance extends beyond simple storage: successful recovery helps maintain continuity in research and production workflows. The quality of the solution and process can therefore affect whether preserved material remains suitable for subsequent bioengineering studies.